These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33590886)

  • 21. A.B.C. approach proposal for POCUS in COVID-19 critically ill patients.
    Simon R; Petrișor C; Bodolea C; Csipak G; Oancea C; Golea A
    Med Ultrason; 2021 Feb; 23(1):94-102. PubMed ID: 33245734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critically ill patients with COVID-19 in New York City.
    Grasselli G; Zanella A
    Lancet; 2020 Jun; 395(10239):1740-1741. PubMed ID: 32442530
    [No Abstract]   [Full Text] [Related]  

  • 23. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
    Buetti N; Mazzuchelli T; Lo Priore E; Balmelli C; Llamas M; Pallanza M; Elzi L; Consonni V; Trimboli P; Forni-Ogna V; Bernasconi E
    J Infect; 2020 Aug; 81(2):e148-e149. PubMed ID: 32512022
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
    Fox TA; Troy-Barnes E; Kirkwood AA; Chan WY; Day JW; Chavda SJ; Kumar EA; David K; Tomkins O; Sanchez E; Scully M; Khwaja A; Lambert J; Singer M; Roddie C; Morris EC; Yong KL; Thomson KJ; Ardeshna KM
    Br J Haematol; 2020 Nov; 191(3):505-506. PubMed ID: 33103782
    [No Abstract]   [Full Text] [Related]  

  • 25. Nutritional support for critically ill patients with COVID-19: New strategy for a new disease?
    Pardo E; Constantin JM; Bonnet F; Verdonk F
    Anaesth Crit Care Pain Med; 2020 Dec; 39(6):738-739. PubMed ID: 33059104
    [No Abstract]   [Full Text] [Related]  

  • 26. Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.
    Soriano MC; Vaquero C; Ortiz-Fernández A; Caballero A; Blandino-Ortiz A; de Pablo R
    J Infect; 2021 Feb; 82(2):e20-e21. PubMed ID: 32956729
    [No Abstract]   [Full Text] [Related]  

  • 27. The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative.
    Li Y; Yang T; Wang S; Zheng J; Zhou J; Jiang M; Zhou T; Cao Y; Wang H
    Bosn J Basic Med Sci; 2021 Apr; 21(2):235-241. PubMed ID: 32893759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19.
    Brubaker L; Mortus J; Cruz M; Trautner B; Loor M; Rosengart T
    J Am Coll Surg; 2021 Feb; 232(2):227-229. PubMed ID: 33246792
    [No Abstract]   [Full Text] [Related]  

  • 29. Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients.
    Frithiof R; Bergqvist A; Järhult JD; Lipcsey M; Hultström M
    Crit Care; 2020 Sep; 24(1):587. PubMed ID: 32993742
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic plasma exchange in a critically ill Covid-19 patient.
    Altmayer V; Saheb S; Rohaut B; Marois C; Cao A; Gallo A; Le Guennec L; Weiss N; Demeret S
    J Clin Apher; 2021 Feb; 36(1):179-182. PubMed ID: 32875601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.
    Zermatten MG; Pantet O; Gomez F; Schneider A; Méan M; Mazzolai L; Hugli O; Bart PA; Papadimitriou-Olivgeris M; Alberio L;
    Thromb Res; 2020 Dec; 196():222-226. PubMed ID: 32916564
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial.
    Pantos C; Tseti I; Mourouzis I
    Crit Care; 2020 May; 24(1):209. PubMed ID: 32384906
    [No Abstract]   [Full Text] [Related]  

  • 33. Unexpected benefits of the COVID challenge: When critically ill adult patients are managed in a pediatric PACU.
    Levy Y; Bonnet MP; Chemam S; Sabourdin N; Louvet N; Constant I
    Paediatr Anaesth; 2020 Aug; 30(8):957-959. PubMed ID: 32959973
    [No Abstract]   [Full Text] [Related]  

  • 34. Study of critically ill patients with COVID-19 in New York City.
    Piovani D; Bonovas S
    Lancet; 2020 Oct; 396(10257):1064. PubMed ID: 33038958
    [No Abstract]   [Full Text] [Related]  

  • 35. Impactful Policy Action to Reduce Drug Costs in Managing Critically Ill Patients with COVID-19.
    Tichy EM; Francis JR
    Mayo Clin Proc; 2020 Aug; 95(8):1808-1809. PubMed ID: 32753159
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical features of critically ill patients with confirmed COVID-19.
    Chu Y; Li T; Fang Q; Wang X
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32360498
    [No Abstract]   [Full Text] [Related]  

  • 37. Copper as a potential adjunct therapy for critically ill COVID-19 patients.
    Fooladi S; Matin S; Mahmoodpoor A
    Clin Nutr ESPEN; 2020 Dec; 40():90-91. PubMed ID: 33183578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the use of corticosteroids for critically ill patients with SARS-CoV-2 interstitial pneumonia].
    Mingoia A; Lejeune F; Sottiaux T; Van Brussel C; Adam JF
    Rev Med Liege; 2020 Sup; 75(S1):133-137. PubMed ID: 33211436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection.
    Copin MC; Parmentier E; Duburcq T; Poissy J; Mathieu D;
    Intensive Care Med; 2020 Jun; 46(6):1124-1126. PubMed ID: 32328726
    [No Abstract]   [Full Text] [Related]  

  • 40. Early Rehabilitation for Critically Ill Patients With COVID-19: More Benefits Than Risks.
    Yu P; Wei Q; He C
    Am J Phys Med Rehabil; 2020 Jun; 99(6):468-469. PubMed ID: 32437114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.